Altasciences Featured Articles

  1. Leveraging Nonclinical Safety Findings To Expedite Next-Generation GLP-1RAs Development 1/7/2025

    Leverage our in-depth analysis of FDA-approved GLP-1RA therapies to identify potential safety concerns and expedite the development of transformative GLP-1RA therapies in early-stage development.

  2. Lipid Nanoparticles: A Comprehensive Assessment Of Liver Enzymes And Immunopathology Markers In Nonhuman Primates 1/7/2025

    Through robust preclinical studies, see how we were able to bridge knowledge gaps and ensure regulatory compliance, thus enhancing the safety and efficacy of lipid nanoparticles.

  3. Comparison Of Safety Pharmacology End Points Used On Toxicology Studies Across Differing Cynomolgus Monkey Origins 1/7/2025

    Leverage robust safety pharmacology data from diverse cynomolgus macaque populations to enhance the accuracy and reliability of your biotherapeutic toxicology studies.

  4. CNS-Targeted Therapies Delivery Strategies And Sampling In Non-Rodent Preclinical Species 1/7/2025

    Ensure optimal tissue analysis and immune response management in preclinical models by using advanced delivery techniques and sampling methods.

  5. Germline Integration Assessment In Preclinical Gene Therapy Studies 1/7/2025

    Ensure the safety of gene therapy products by utilizing advanced preclinical methods and DNA isolation techniques to evaluate the potential for germline integration and minimize offspring risks.

  6. Safety Assessment For Ophthalmic Products 1/7/2025

    Plan your ocular drug development strategy with comprehensive preclinical studies to ensure regulatory success and smooth progression to first-in-human trials.

  7. Nonclinical Safety Testing Guide 1/7/2025

    Are you equipped with the tools you need to plan your preclinical studies? Check out this essential checklist to help plan your preclinical safety assessments.

  8. Key Considerations For Nonclinical AAV Gene Therapy Development 1/7/2025

    Looking to learn more on nonclinical AAV gene therapy development? Check out this essential eBook that will provide the latest insights on AAV gene therapy.

  9. A Changing Paradigm For Non-Rodent Species In Nonclinical Safety Studies 1/7/2025

    The choice of species for nonclinical safety studies is an important step in the drug development process. Check out this scientific journal which outlines vital considerations for species selection.

  10. Nonclinical Studies In Cell and Gene Therapy 1/7/2025

    Looking for best practices and expert tips on how to address challenges and improve study efficiency in nonclinical gene therapy studies? Check out this scientific journal today!